Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
schizophrenia. ALKS 9070
.
Show all posts
Showing posts with label
schizophrenia. ALKS 9070
.
Show all posts
Sunday, January 1, 2012
Alkermes commences ALKS 9070 phase 3 clinical trial for schizophrenia...
›
Alkermes plc (NASDAQ: ALKS) announced the initiation of a phase 3 clinical trial of ALKS 9070 ( Aripiprazole ) for the treatment of schi...
1 comment:
›
Home
View web version
